LENSAR, Inc.
NASDAQ:LNSRMedical - Devices
-$0.51 today
- Market cap
- $59.63M
- Beta
- 0.87
- P/E (TTM)
- 2.4
- EPS (TTM)
- $2.42
Volume 0.06M
Average 0.09M
LNSR Common Stock Issued
Cash raised by issuing new shares.
LENSAR, Inc.NASDAQ: LNSR
Common Stock Issued · Q1 FY2026 · quarter ended Mar 2026
Common stock issued dips below year-ago levels
Q1 FY2026 common stock issued of $15K fell 28.6% year over year, behind the +814.9% change in trailing-twelve-month common stock issued. Sequentially, it fell 96.8% from the prior quarter. Over 3 fiscal years it compounded at -14.2% a year.
Context
- Common stock issued amounted to 0.4% of revenue in FY2025, up 0.3 pp from a year earlier.
- Common stock issued increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -28.6% toward the trailing-twelve-month pace of +814.9%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2025
- 258K USD
- Year-over-year change
- +344.8%
- 4-year CAGR
- -8.1%
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 258K | +344.8% |
| FY2024 | 2024-12-31 | 58K | — |
| FY2023 | 2023-12-31 | 0 | -100.0% |
| FY2022 | 2022-12-31 | 408K | +13.0% |
| FY2021 | 2021-12-31 | 361K | — |
Common Stock Issued vs competitors
How LNSR compares with its peers on the latest reported figures
- LNSR's LTM Mar 2026 common stock issued of $677K is the 8th largest of the 10 companies compared; the peer median is $35.08M.
- Its year-over-year change of +814.9% is the highest of 9, against a peer median of +62.8%.
- Common stock issued amounts to 1.2% of revenue for LNSR, versus a peer median of 89.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | $323.67M | +180.3% | -3.1% | 17486.4% |
| LTM Mar 2026 | $77.35M | +115.3% | — | — | |
| LTM Mar 2026 | $65.24M | +414.7% | — | 145.3% | |
| LTM Mar 2026 | $43.19M | +10.3% | — | 228.9% | |
| LTM Mar 2026 | $35.08M | +238.3% | — | 32.8% | |
| LTM Mar 2026 | $2.66M | -95.0% | +225.3% | 506.3% | |
| LTM Mar 2026 | $968K | — | — | 2.8% | |
| LTM Mar 2026 | $677K | +814.9% | -14.2% | 1.2% | |
| LTM Mar 2026 | $500K | +7.8% | -9.8% | 0.4% | |
| LTM Mar 2026 | $278K | -84.0% | -39.0% | 0.9% | |
| Peer median (excluding LNSR) | $35.08M | +62.8% | -6.4% | 89.1% | |
Competitors are the stored peer set for LNSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (19.6M) | (19.91M) | (14.38M) | (31.4M) | (34.28M) |
| Depreciation & Amortization | 2.76M | 3.41M | 3.52M | 3.93M | 4.5M |
| Deferred Income Tax | 527K | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 6.87M | 6.61M | 5.54M | 2.67M | 3.14M |
| Change in Working Capital | (42K) | (5.58M) | (7.78M) | (3.04M) | 1.1M |
| Accounts Receivables | (2.65M) | (1.44M) | 1.08M | (2.1M) | 289K |
| Inventory | 2.33M | (6.89M) | (7.46M) | (4.9M) | (13.9M) |
| Accounts Payables | 213K | 2.73M | (1.42M) | 1.96M | 12.99M |
| Other Working Capital | 66K | 23K | 23K | 2M | 1.72M |
| Other Non-Cash Items | 517K | 618K | 3.45M | 25.58M | 10.7M |
| Operating Cash Flow | (8.97M) | (14.86M) | (9.66M) | (2.28M) | (14.83M) |
| Capital Expenditures | (354K) | (115K) | (236K) | (156K) | (83K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | (3.92M) | (10.25M) | (11.88M) |
| Sales of Investments | 0 | 0 | 0 | 8.24M | 13.25M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (354K) | (115K) | (4.16M) | (2.16M) | 1.28M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 361K | 408K | 0 | 58K | 258K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (2.4M) | 5.88M | 20K | 10M |
| Financing Cash Flow | 361K | (1.99M) | 19.76M | 78K | 10.26M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (8.96M) | (16.96M) | 5.95M | (4.36M) | (3.29M) |
| Free Cash Flow | (9.32M) | (14.97M) | (9.9M) | (2.43M) | (14.91M) |
LENSAR, Inc.
NASDAQ:LNSR
Intrinsic Alpha fair value
Locked
Current Price
$4.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.